Management of American cutaneous leishmaniasis: Outcome of high-dose Pentamidine isethionate treatment of 326 cases;Therapeutique des leishmanioses tegumentaires du nouveau monde experience a propos de 326 cas traites par isethionate de pentamidine a fortes doses

Medecine Tropicale

Volumn 63, Issue 1, 2003, Pages 35-44

  Lightburn, E ^a   Morand, J J ^a   Meynard, J B ^b   Kraemer, P ^a   Chaudier, B ^a   Pages, F ^a   Garnotel, E ^a   Patte, J H ^a   Banzet, S ^c   Dampierre, H ^c   Lepage, J ^d   Morillon, M ^a   Boutin, J P ^b   Hovette, P ^a   Chouc, C ^a  

^a LAVERAN MILITARY TEACHING HOSPITAL   (France)

^b SERVICE DE SANTÉ DES ARMÉES   (France)

^c Direction Interarmées ^*  (Guyana)

^d Service de Santé en Guyane   (Guyana)

Author keywords

American cutaneous leishmaniasis; Antimonial derivatives; French guyana; Immunotherapy; Miltefosine; Paromycine; Pentamidine isethionate; Rhabdomyolysis

Indexed keywords

ANTIMONY DERIVATIVE; MILTEFOSINE; PAROMOMYCIN; PENTAMIDINE ISETHIONATE; ANTIPROTOZOAL AGENT; PENTAMIDINE;

ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; EPIDEMIC; FRANCE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; PUBLIC HOSPITAL; RHABDOMYOLYSIS; SKIN LEISHMANIASIS; SOLDIER; TREATMENT FAILURE; TREATMENT OUTCOME; CHEMICALLY INDUCED DISORDER; ETHNOLOGY; FRENCH GUIANA; INTRAMUSCULAR DRUG ADMINISTRATION; RETROSPECTIVE STUDY;

ANTIPROTOZOAL AGENTS; FRANCE; FRENCH GUIANA; HUMANS; INJECTIONS, INTRAMUSCULAR; LEISHMANIASIS, CUTANEOUS; MILITARY PERSONNEL; PENTAMIDINE; RETROSPECTIVE STUDIES; RHABDOMYOLYSIS; TREATMENT OUTCOME;

EID: 0141707056     PISSN: 0025682X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. LIGHTBURN E, MEYNARD JB, MORAND JJ et Coll - Surveillance épidémiologique des leishmanioses tégumentaires en Guyane. Synthèse de données militaires sur 10 ans. Med Trop 2002; 62: 545-553.
2. LIGHTBURN E, MORAND JJ, GARNOTEL E et Coll - Panorama clinique des leishmanioses tégumentaires du nouveau Monde. Med Trop 2002; 62: 637-656.
3. BUFFET P, CAUMES E, GENTILINI M - Traitement des leishmanioses cutanées localisées. Ann Dermatol Venereol 1994; 121: 503-511.
4. SOTO-MANCIPE J, GROGL M, BERMAN J - Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia. Clin Infect Dis 1993; 16: 417-425.
5. SOTO-MANCIPE J, BUFFET P, GROGL M, BERMAN J - Successful treatment of Colombian cutaneous leishmaniasis with four injections of pentamidine. Am J Med Hyg 1994; 50: 107-111.
6. LAI A FAT EJ, VREDE MA, SOETOSENOJO RM, LAI A FAT RF - Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam. Int J Dermatol 2002; 41: 796-800.
7. LOW-A-CHEE R, ROSE P, RIDLEY D - An outbreak of cutaneous leishmaniasis in Guyana: epidemiology, clinical and laboratory aspects. Ann Trop Med Parasitol 1983; 77: 255-260.
8. TALHARI S, GOMES SARDINHA JC, MENDES SCHETTINI AP, ARIAS J, NAIFF RD - Tratamento da leishmaniose tegumentar americana. Resultados preliminares con a pentamidina. An Bras Dermatol 1985; 60: 361-364.
9. PRADINAUD R, SERVANS G, SAINTE-MARIE D et Coll - Bilan de 10 années de traitement de la leishmaniose tégumentaire par la pentamidine en Guyane Française: à propos de 1025 cas. Nouv Dermatol 1991; 10: 456-461.
10. PRADINAUD R - Le traitement de la leishmaniose tégumentaire par la pentamidine en Guyane Française. Med Trop 1994; 54: 418-22.
11. PRADINAUD R - Comment traiter une leishmaniose cutanée avec l'iséthionate de pentamidine? Nouv Dermatol 1999; 18: 352.
12. NACHER M, CARME B, SAINTE MARIE D et Coll - Influence of clinical presentation on the efficacy of a short course pentamidine in the treatment of cutaneous leishmaniasis in French Guiana. Ann Trop Med Parasitol 2001; 95: 331-336.
13. PRATLONG F, MARTINI A, LAMBERT M et Coll - Intérêt de la culture et de l'identification isoenzymatique des leishmanies dans le diagnostic et l'épidémiologie des leishmanioses. Medecine et Armees 1994; 22: 61-65.
14. MOSKOWITZ PF, KURBAN AK - Treatment of cutaneous leishmaniasis: Retrospectives and advances for the 21st century. Clin Dermatol 1999; 17: 305-315.
15. DEDET JP - Cutaneous leishmaniasis in French Guiana: a review. Am J Trop Med Hyg 1990; 43: 25-28.
16. LARRIVIERE-CHOUC C, ARMINGAUD P, BRANQUET D et Coll -Résurgences de leishmaniose cutanée après traitement en Guyane: prise en charge thérapeutique à propos de 15 observations. Nouv Dermatol 1996; 15: 530-532.
17. SANDS M, KRON MA, BROWN RN - Pentamidine: a review. Rev Infect Dis 1985; 7: 625-634.
18. VEENSTRA J, SMIT WM, KREDIET RT, ARISZ L - Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis. Nephrol Dial Transplant 1994; 9: 637-641.
19. CHICHMANIAN RM, MIGNOT G, SPREUX A - Rhabdomyolyses mé dicamenteuses. Ann Med Int 1991; 142: 587-591.
20. GABOW PA, KAEHNY WD, KELLEHER SP - The spectrum of rhabdomyolysis. Medicine (Baltimore) 1982; 61: 141-152.
21. SENSAKOVIC JW, SUAREZ M, PEREZ G et Coll - Pentamidine treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Association with acute renal failure and myoglobinuria. Arch Intern Med 1985; 145: 2247.
22. LIGHTBURN E, MORAND J-J, PAGES F et Coll - Leishmaniose tégumentaire du Nouveau Monde: 37 observations en milieu militaire au retour de Guyane Française en 1999. Nouv Dermatol 2000; 19: 389-394.
23. LIEBER-MBOMEYO A, LIPSKER D, MILEA M, HEID E - Rhabdomyolyse induite par l'iséthionate de pentamidine (Pentacarinat) lors du traitement d'une leishmaniose cutanée: 2 cas. Ann Derm Venereol 2002; 129: 50-2.
24. NAVIN T, ARANA B, ARANA F, et coll. - Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis 1992; 165: 528-534.
25. HEPBURN N, TIDMAN M, HUNTER J - Aminosidine (paramomycine) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis. Trans Soc R Trop Med Hyg 1994; 88: 700-703.
26. VELEZ I, AGUDELO S, HENDRICKX E, et coll. - Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis: a randomised, controlled triad. Ann Intern Med 1997; 126: 232-236.
27. SAENZ R, PAZ H, BERMAN J - Efficacy of Ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis. Am J Med 1990; 89: 147-155.
28. MARTINEZ S, GONZALES M, VERNAZA M - Treatment of cutaneous leishmaniasis with allopurinol and stibogluconate. Clin Infect Dis I997; 126: 232-236.
29. ARANA B, NAVIN T, ARANA F, et coll. - Efficacy of a short course (10 days) of high-dose meglumine antimoniate with or without interferon-(in treating cutaneous leishmaniasis in Guatemala. Clin Infect Dis 1994; 18: 381-384.
30. OLIVEIRA-NETO M, SCHUBACH A, MATTOS M et Coll - A low dose antimony treatment in 159 patients with American cutaneous leishmaniasis: extensive follow-up studies (up to 10 years). Am J Trop Med Hyg 1997; 57: 651-655.
31. WORTMANN G, MILLER RS, OSTER C et Coll - A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel. Clin Infect Dis 2002; 35: 261-267.
32. ROMERO GA, GUERRA MV, PAES MG, MACEDO VO - Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate. Am J Trop Med Hyg 2001; 65: 456-65.
33. KOCYIGIT A, GUR S, GUREL MS et Coll - Antimonial therapy induces circulating proinflammatory cytokines in patients with cutaneous leishmaniasis. Infect Immun 2002; 70: 6589-91.
34. MACHADO P, ARAUJO C, DA SILVA AT et Coll - Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer. Clin Infect Dis 2002; 34: 69-73.
35. PALACIOS R, OSORIO LE, GRAJALEW LF, OCHOA MT - Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonata for cutaneous leishmaniasis due to species. Am J Trop Med Hyg 2001; 64: 187-193.
36. LESSA HA, MACHADO P, LIMA F et Coll - Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. Am J Trop Med Hyg 2001; 65: 87-89.
37. WARTMAN G, FRASER S, ARONSON N et Coll - Failure of amphotericin B lipid complex in the treatment of cutaneous leishmaniasis. Clin Infect Dis 1998; 26: 1006-1007.
38. BECKER I, VOLKOW P, VELASCO-CASTREJON O et Coll - The efficacy of pentamidine combined with allopurinol and immunotherapy for the treament of patients with diffuse cutaneous leishmaniasis. Parasitol Res 1999; 85: 165-70.
39. DEDET JP, PAPET P, ESTERRE P et Coll - Echec du kétoconazole dans le traitement de la leishmaniose cutanée à Leishmania braziliensis guyanensis en Guyane Française. Med Mal Infect 1987; 1: 4-8.
40. ALRAJHI AA, IBRAHIM EA, DE VOL EB et Coll - Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med 2002; 346: 891-895.
41. OSORIO L, PALACIOS R, CHICA M, OCHOA M - Treatment of leishmaniasis in Colombia with dapsone. Lancet 1998; 351: 498-499.
42. GENARO O, TOLEDO VP, DA COSTA CA et Coll - Vaccine for prophylaxis and immunotherapy. Brazil Clin Dermatol 1996; 14: 503-512.
43. MAYRINK W, PINTO J, DA COSTA CA et Coll - Evaluation of the potency and stability of a candidate vaccine against American cutaneous leishmaniasis. Am J Trop Med Hyg 1999; 61: 294-295.
44. MACHADO-PINTO J, PINTO J, DA COSTA CA et Coll -Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial. Int J Dermatol 2002; 41: 73-78.
45. ARMIJOS RX, WEIGEL MM, AVILES H et Coll - Field trial of a vaccine against New World cutaneous leishmaniasis in an at-risk child population: safety, immunogenicity, and efficacy during the first 12 months of follow-up. J Infect Dis 1998; 177: 1352-1357.
46. VELEZ ID, DEL PILAR AGUDELO S, ARBELAEZ MP et Coll -Safety and immunogenicity of a killed Leishmania (L.) amazonensis vaccine against cutaneous leishmaniasis in Colombia: a randomized controlled trial. Trans R Soc Trop Med Hyg 2000; 94: 698-703.
47. SUNDAR S, JHA TK, THAKUR CP, ENGEL J et Coll - Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med 2002; 347: 1739-1746
48. SOTO J, TOLEDO J, GUTIERREZ P et Coll - Treatment of American Cutaneous Leishmaniasis with Miltefosine, an Oral Agent. Clin Infect Dis 2001; 33: 57-61.
49. SCHMIDT-OTT R, KLENNER T, OVERATH P, AEBISCHER T - Topical treatment with hexadecylphosphocholine (Miltex) efficiently reduces parasite burden in experimental cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1999; 93: 85-90.
50. GAMIER T, CROFT SL - Topical treatment for cutaneous leishmaniasis. Curr Opin Investig Drugs 2002; 3: 538-544.
51. EL-ON J, HALEVY S, GRUNWALD MH, WEINRAUCH L - Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study. J Am Acad Dermatol 1992; 27: 227-231.
52. KRAUSE G, KROEGER A - Topical treatment of American cutaneous leishmaniasis with paromomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador. Trans R Soc Trop Med Hyg 1994; 88: 92-94.
53. SOTO J, FUYA P, HERRERA R, HERMAN J - Topical paromomycin methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study. Clin Infect Dis 1998; 26: 56-58.
54. ARANA BA, MENDOZA CE, RIZZO NR, KROEGER A - Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala. Am J Trop Med Hyg 2001; 65: 466-470.
55. SOTO JM, TOLEDO JT, GUTIERREZ P et Coll - Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study. Am J Trop Med Hyg 2002; 66: 147-151.
56. VARDY D, BARENHOLZ Y, NAFTOLIEV N et Coll - Efficacious topical treatment for human cutaneous leishmaniasis with ethanolic lipid amphotericin B. Trans R Soc Trop Med Hyg 2001; 95: 184-6
57. CLIVE S, LEONARD RC - Miltefosine in reccurent cutaneous breast cancer. Lancet 1997; 349: 621-622.
58. LOPEZ-JARAMILLO P, RUANO C, RIVERA J et Coll - Treatment of cutaneous leishmaniasis with nitric-oxide donor. Lancet 1998; 351: 1176-1177.
59. AREVALO I, WARD B, MILLER R et Coll - Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator. Clin Infect Dis 2001; 33: 1847-1851.